Oppenheimer & Co’s Compugen CGEN Stock Holding History

Oppenheimer & Co’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$39.3K	Buy	16,500 +1,000	+6%	+$2.43K	﹤0.01%	1734
2026 Q2	$33.2K	Buy	+15,500	New	+$38.8K	﹤0.01%	1748
2025 Q3	–	Sell	-17,050	Closed	-$30.3K	–	1663
2025 Q2	$30.3K	Sell	17,050 -39,552	-70%	-$58.7K	﹤0.01%	1589
2025 Q1	$82.6K	Buy	56,602 +1,000	+2%	+$1.95K	﹤0.01%	1525
2024 Q4	$85.1K	Buy	55,602 +36,252	+187%	+$58.9K	﹤0.01%	1513
2024 Q3	$35K	Buy	19,350 +8,350	+76%	+$15.2K	﹤0.01%	1488
2024 Q2	$18.5K	Sell	11,000 -5,000	-31%	-$10.4K	﹤0.01%	1422
2024 Q1	$41.3K	Sell	16,000 -5,000	-24%	-$11.6K	﹤0.01%	1416
2023 Q4	$41.6K	Sell	21,000 -15,000	-42%	-$13.1K	﹤0.01%	1353
2023 Q3	$33.5K	Sell	36,000 -16,000	-31%	-$17.6K	﹤0.01%	1353
2023 Q2	$59.3K	Buy	52,000 +15,500	+42%	+$13.5K	﹤0.01%	1378
2023 Q1	$25.6K	Hold	36,500	–	–	﹤0.01%	1357
2022 Q4	$26.1K	Buy	36,500 +5,000	+16%	+$4.36K	﹤0.01%	1328
2022 Q3	$21K	Buy	31,500 +15,000	+91%	+$21.2K	﹤0.01%	1344
2022 Q2	$31K	Hold	16,500	–	–	﹤0.01%	1377
2022 Q1	$53K	Buy	16,500 +5,000	+43%	+$16.9K	﹤0.01%	1434
2021 Q4	$49K	Buy	+11,500	New	+$62.2K	﹤0.01%	1467

Other funds holding CGEN

Taylor Frigon Capital Management Scottsdale, Arizona $197M AUM 35.01% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $549M AUM 46.93% 1-Year Est. Return

Matrix Asset Advisors White Plains, New York $1.21B AUM 19.26% 1-Year Est. Return

Eagle Rock Investment Company Atlanta, Georgia $799M AUM 33.32% 1-Year Est. Return

Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return

BIP Wealth Atlanta, Georgia $3.69B AUM 12.44% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Oppenheimer & Co's CGEN Position: Q3 2026 in Review

Oppenheimer & Co increased its Compugen (CGEN) stake by 6.5% in Q3 2026, buying an estimated $2.43K and bringing the position to 16,500 shares worth $39.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Oppenheimer & Co first reported a position in CGEN in Q4 2021 and has held it in 17 quarters since. The position peaked at $85.1K in Q4 2024. 9 funds tracked by Wall St. Rank hold CGEN as of Q3 2026.

Oppenheimer & Co held 16,500 shares of Compugen worth $39.3K as of Q3 2026.
Oppenheimer & Co bought 1,000 Compugen shares in Q3 2026, an estimated $2.43K.
Compugen made up ﹤0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #1734 holding.
Oppenheimer & Co first reported a position in Compugen in Q4 2021 and has held it in 17 quarters since.
Oppenheimer & Co's Compugen position peaked at $85.1K in Q4 2024.
9 funds tracked by Wall St. Rank held Compugen as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.